Fact CheckerSign in

NCT07360769Completed

Optimizing Hemodialysis: How Low Dialysate Flow Alters Adequacy and Patient Recovery.

Low Dialysate Flow: Its Effect on Hemodialysis Adequacy, Dialysis Recovery Time and Patient Reported Outcome Measures.

Source: ClinicalTrials.gov · Last updated 22 Jan 2026

Brief summary (registry, in English)

The goal of this clinical trial is to detect if lower dialysate flow rate can affect hemodialysis adequacy , dialysis recovery time and patients quality of life. The main questions it aims to answer are: does low dialysate flow affect hemodialysis adequacy? does green dialysis achievable without affecting hemodialysis adequacy? Researchers will compare hemodialysis session of high dialysate flow to that with low dialysate flow. Participants will: underwent hemodialysis for a week with low dialysate flow and another week with high dialysate flow.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
15 Dec 2025
Start date
1 Jun 2025
Primary completion date
30 Aug 2025
Lead sponsor
Alexandria University
NCT number
NCT07360769

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Jun 2025 to the primary completion date, 30 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with terminal malignancy or receiving chemotherapy.
  • Patients receiving immune suppression treatment.

Other

  • Critically ill and hospitalized ESKD patients.
  • Mentally disabled patients.

Who the study is looking for

  • ESKD patients more than or equal 18 years old, on maintenance HD thrice weekly for more than three months and each session lasts for 4 hours.
  • All patients will receive HD via an arterio-venous fistula.
  • All patients will receive HD via the same type of HD machine and the blood pump will be set at 300ml/min.
  • All patients will receive the same type of HD membranes and every effort will be made to achieve the dry weight of the patients.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine, Alexandria University
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.